These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38956819)

  • 1. The protective effects of repetitive transcranial magnetic stimulation with different high frequencies on motor functions in MPTP/probenecid induced Parkinsonism mouse models.
    Lyu Z; Xiao G; Xie D; Huang D; Chen Y; Wu C; Lai Y; Song Z; Huang L; Ming H; Jiang Y; Wang J; Chen R; Luo W
    Brain Behav; 2024 Jul; 14(7):e3605. PubMed ID: 38956819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
    Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.
    Sconce MD; Churchill MJ; Greene RE; Meshul CK
    Neuroscience; 2015 Jul; 299():156-74. PubMed ID: 25943481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of repetitive transcranial magnetic stimulation in an animal model of Parkinson's disease.
    Lee JY; Kim SH; Ko AR; Lee JS; Yu JH; Seo JH; Cho BP; Cho SR
    Brain Res; 2013 Nov; 1537():290-302. PubMed ID: 23998987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Repetitive Transcranial Magnetic Stimulation Exerts Neuroprotective Effects and Improves Motor Functions in Hemiparkinsonian Rats.
    Hsieh TH; He XK; Liu HH; Chen JJ; Peng CW; Liu HL; Rotenberg A; Chen KT; Chang MY; Chiang YH; Chang PK; Kuo CW
    Neural Plast; 2021; 2021():1763533. PubMed ID: 34987572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escin attenuates behavioral impairments, oxidative stress and inflammation in a chronic MPTP/probenecid mouse model of Parkinson's disease.
    Selvakumar GP; Janakiraman U; Essa MM; Justin Thenmozhi A; Manivasagam T
    Brain Res; 2014 Oct; 1585():23-36. PubMed ID: 24657313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influences of Chronic Mild Stress Exposure on Motor, Non-Motor Impairments and Neurochemical Variables in Specific Brain Areas of MPTP/Probenecid Induced Neurotoxicity in Mice.
    Janakiraman U; Manivasagam T; Thenmozhi AJ; Essa MM; Barathidasan R; SaravanaBabu C; Guillemin GJ; Khan MA
    PLoS One; 2016; 11(1):e0146671. PubMed ID: 26765842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment.
    Petroske E; Meredith GE; Callen S; Totterdell S; Lau YS
    Neuroscience; 2001; 106(3):589-601. PubMed ID: 11591459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of CDNF by AAV-mediated gene transfer protects dopamine neurons and regulates ER stress and inflammation in an acute MPTP mouse model of Parkinson's disease.
    Nam J; Richie CT; Harvey BK; Voutilainen MH
    Sci Rep; 2024 Jul; 14(1):16487. PubMed ID: 39019902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
    J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra.
    Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH
    Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism.
    Faherty CJ; Raviie Shepherd K; Herasimtschuk A; Smeyne RJ
    Brain Res Mol Brain Res; 2005 Mar; 134(1):170-9. PubMed ID: 15790541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of dopamine neurons by vibration training and up-regulation of brain-derived neurotrophic factor in a MPTP mouse model of Parkinson's disease.
    Zhao L; He LX; Huang SN; Gong LJ; Li L; Lv YY; Qian ZM
    Physiol Res; 2014; 63(5):649-57. PubMed ID: 24908088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study.
    Blesa J; Pifl C; Sánchez-González MA; Juri C; García-Cabezas MA; Adánez R; Iglesias E; Collantes M; Peñuelas I; Sánchez-Hernández JJ; Rodríguez-Oroz MC; Avendaño C; Hornykiewicz O; Cavada C; Obeso JA
    Neurobiol Dis; 2012 Oct; 48(1):79-91. PubMed ID: 22677034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease.
    Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT
    J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise in an animal model of Parkinson's disease: Motor recovery but not restoration of the nigrostriatal pathway.
    Churchill MJ; Pflibsen L; Sconce MD; Moore C; Kim K; Meshul CK
    Neuroscience; 2017 Sep; 359():224-247. PubMed ID: 28754312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson's disease with moderate neurodegeneration.
    Lau YS; Patki G; Das-Panja K; Le WD; Ahmad SO
    Eur J Neurosci; 2011 Apr; 33(7):1264-74. PubMed ID: 21375602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease.
    Zheng M; Liu C; Fan Y; Yan P; Shi D; Zhang Y
    Neuropharmacology; 2017 Apr; 116():412-420. PubMed ID: 28093210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mulberry fruit ameliorates Parkinson's-disease-related pathology by reducing α-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model.
    Gu PS; Moon M; Choi JG; Oh MS
    J Nutr Biochem; 2017 Jan; 39():15-21. PubMed ID: 27741433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcranial alternating current stimulation rescues motor deficits in a mouse model of Parkinson's disease via the production of glial cell line-derived neurotrophic factor.
    Lee HJ; Jung DH; Jung YJ; Shin HK; Choi BT
    Brain Stimul; 2022; 15(3):645-653. PubMed ID: 35429660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.